Current CEO Timo Lehtonen is transferring into a new role in the company, according to te release. During his tenure he saw the company through the first FDA market authorization of magnesium-based implants.
Mr. Lehtonen will stay with the company until a successor is appointed.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
